Therapeutic use of siltuximab for the treatment of breast cancer has not been fully evaluated, although preliminary studies with the estrogen receptor alpha positive MCF-7 breast cancer cell line suggests potential efficacy [90]. Here, ESR1 is linked to breast carcinoma.